Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WATER IV Prostate Cancer: Aquablation Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer

NCT06651632 is registered in ClinicalTrials.gov with PROCEPT BioRobotics as lead sponsor.

NCT NCT06651632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06651632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WATER IV Prostate Cancer: Aquablation Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer
Lead sponsor
PROCEPT BioRobotics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 3, 2025
Completion date
January 31, 2037
Enrollment
280 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate cancer